Bafna Pharmaceuticals Limited (BAFNAPH) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.102x

Based on the latest financial reports, Bafna Pharmaceuticals Limited (BAFNAPH) has a cash flow conversion efficiency ratio of 0.102x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs93.12 Million ≈ $1.01 Million USD) by net assets (Rs912.28 Million ≈ $9.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BAFNAPH net asset quality index to measure how much of total assets are equity-financed.

Bafna Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2005–2026)

This chart illustrates how Bafna Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check BAFNAPH cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Bafna Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bafna Pharmaceuticals Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Lumos Diagnostics Holdings Ltd AU:LDX	0.149x
CAIRO MEZZ PLC EO-10 F:6H3	N/A
United Palm Oil Industry Public Company Limited BK:UPOIC	0.065x
Grupo Greening 2022 SA MC:GGR	N/A
Ene Technology Inc TW:6243	0.037x
Country Group Holdings Public Company Limited BK:CGH	0.024x
Tex Year Industries Inc TW:4720	0.013x
TPL Plastech Limited NSE:TPLPLASTEH	0.277x

Annual Cash Flow Conversion Efficiency for Bafna Pharmaceuticals Limited (2005–2026)

The table below shows the annual cash flow conversion efficiency of Bafna Pharmaceuticals Limited from 2005 to 2026. For the full company profile with market capitalisation and key ratios, see BAFNAPH market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs1.00 Billion ≈ $10.83 Million	Rs118.27 Million ≈ $1.28 Million	0.118x	-48.72%
2025-03-31	Rs848.07 Million ≈ $9.17 Million	Rs195.29 Million ≈ $2.11 Million	0.230x	+96.27%
2024-03-31	Rs808.39 Million ≈ $8.74 Million	Rs94.85 Million ≈ $1.03 Million	0.117x	+74.02%
2023-03-31	Rs734.55 Million ≈ $7.94 Million	Rs49.52 Million ≈ $535.59K	0.067x	-57.06%
2022-03-31	Rs619.64 Million ≈ $6.70 Million	Rs97.28 Million ≈ $1.05 Million	0.157x	+165.49%
2021-03-31	Rs567.71 Million ≈ $6.14 Million	Rs-136.09 Million ≈ $-1.47 Million	-0.240x	+64.19%
2020-03-31	Rs511.95 Million ≈ $5.54 Million	Rs-342.68 Million ≈ $-3.71 Million	-0.669x	-606.06%
2019-03-31	Rs188.52 Million ≈ $2.04 Million	Rs-17.87 Million ≈ $-193.28K	-0.095x	+49.95%
2018-03-31	Rs372.02 Million ≈ $4.02 Million	Rs-70.47 Million ≈ $-762.14K	-0.189x	-742.20%
2017-03-31	Rs421.12 Million ≈ $4.55 Million	Rs-9.47 Million ≈ $-102.44K	-0.022x	-242.15%
2016-03-31	Rs575.71 Million ≈ $6.23 Million	Rs9.11 Million ≈ $98.52K	0.016x	-89.21%
2015-03-31	Rs727.13 Million ≈ $7.86 Million	Rs106.65 Million ≈ $1.15 Million	0.147x	+536.93%
2014-03-31	Rs697.48 Million ≈ $7.54 Million	Rs16.06 Million ≈ $173.70K	0.023x	-95.71%
2013-03-31	Rs683.04 Million ≈ $7.39 Million	Rs366.32 Million ≈ $3.96 Million	0.536x	+460.94%
2012-03-31	Rs646.17 Million ≈ $6.99 Million	Rs-96.01 Million ≈ $-1.04 Million	-0.149x	-26.74%
2011-03-31	Rs541.89 Million ≈ $5.86 Million	Rs-63.53 Million ≈ $-687.07K	-0.117x	-708.49%
2010-03-31	Rs410.05 Million ≈ $4.43 Million	Rs-5.95 Million ≈ $-64.31K	-0.015x	+96.00%
2009-03-31	Rs385.23 Million ≈ $4.17 Million	Rs-139.82 Million ≈ $-1.51 Million	-0.363x	-105.51%
2008-03-31	Rs118.55 Million ≈ $1.28 Million	Rs-20.94 Million ≈ $-226.43K	-0.177x	-115.97%
2007-03-31	Rs91.39 Million ≈ $988.34K	Rs101.06 Million ≈ $1.09 Million	1.106x	+1151.53%
2006-03-31	Rs56.78 Million ≈ $614.05K	Rs-5.97 Million ≈ $-64.57K	-0.105x	+83.71%
2005-03-31	Rs42.55 Million ≈ $460.13K	Rs-27.46 Million ≈ $-297.02K	-0.646x	--

About Bafna Pharmaceuticals Limited

NSE:BAFNAPH India Drug Manufacturers - Specialty & Generic

Market Cap

$68.61 Million

Rs6.34 Billion INR

Market Cap Rank

#20627 Global

#1148 in India

Share Price

Rs268.20

Change (1 day)

+2.01%

52-Week Range

Rs81.38 - Rs268.20

All Time High

Rs507.50